Humate-P is a replacement therapy treatment of von Willebrand disease (VWD). Trusted by patients for decades, Humate-P is the only human plasma-derived von Willebrand factor (HP-VWF/FVIII) concentrate that is approved for the treatment of all VWD types* and for the prevention of excessive bleeding during and after all surgery procedures.
Humate-P
Von Willebrand Disease Treatment
2024-08-21
Humate-P works by replacing the VWF/FVIII complex that is deficient or defective in patients with von Willebrand disease. The HP-VWF/FVIII concentrate is purified from pooled human plasma from many carefully screened plasma donors and contains the clotting proteins VWF and FVIII.